Pharmaceutical industry is among the most highly rated and innovative industries in the world. Dmytro Shymkiv, the chairman of the Darnitsa Groups board of directors, asserted this and noted that the Ukrainian manufacturers of medicinal products have once again made it to the top most rapidly developing companies. Having said that, he noted that domestic pharmaceutical products in terms of technological processes and quality are as good as European counterparts.
According to the top manager of Darnitsa, in the course of the program to preserve and increase the sales market, Darnitsa Group has taken a leading position in the Ukrainian pharmaceutical industry. Without any doubt, the worldwide Covid-19 pandemic pushed the plant’s management to look for alternative approaches to production solutions. Weathering the pandemic, the concern has activated all its reserves in order to provide Ukrainian consumers with affordable medicines of its own production as much as possible.
Analyzing the state of the global pharmaceutical market, Dmytro Shymkiv notes that the leader in the innovative segment now is the industry that develops and manufactures pharmaceutics. Top positions in the rating are occupied by the recognized authorities – Moderna, Pfizer, Novavax, Jonson & Jonson, AstraZeneca. These pharmaceutical corporations have become leaders because they were able to test, mass-produce and realize in the global market an effective Covid-19 vaccine in less than a year. This success stimulates other pharmaceutical companies to continuously and systematically introduce new technologies in the production of drugs.
In turn, Darnitsa Group launched a non-stop innovation process, which allowed it to achieve significant investments in new projects and developments. The statistical data shows that the concern is the leader in the domestic pharmaceutical industry in terms of the volume of products sold. Dmytro Shymkiv also stated that the traditional distrust of Ukrainians towards local pharmaceutical manufacturers is groundless. As proof of his words, he announced the official data. According to them, the Ukrainian drugs produced by the Darnitsa company pass the final stages of research in the laboratories of the EU countries, fully comply with European requirements and are successfully sold in the EU markets.